Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 300, Issue 1-2, Pages 120-129Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2010.09.005
Keywords
Ischemia; PPAR gamma; Rosiglitazone; Delayed neuronal death; Neuroprotection; Hippocampus; Gerbil
Categories
Funding
- Ministry for Health, Welfare and Family Affairs, Republic of Korea [A08-4866-A21723-08N1-00010A]
Ask authors/readers for more resources
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is expressed in neurons and glia, and its synthetic agonist, rosiglitazone (RSG), regulates inflammatory process and has neuroprotective effects against neurological disorders. In the present study, we examined the role of PPAR gamma in the hippocampal CA1 region (CA1) after transient cerebral ischemia and the neuroprotective effects of RSG on ischemic damage. RSG attenuated neuronal damage in the ischemic CA1, not showing perfect neuroprotection: the RSG appeared to delay neuronal death after ischemia/reperfusion (I/R). PPAR gamma immunoreactivity and protein levels were increased after I/R, and most of PPAR gamma-immunoreactive cells colocalized with microglia, not astrocytes. In addition, RSG attenuated glial activation and increased IL-4 and IL-13 levels in the ischemic CAL These results indicate that PPAR gamma increases and expresses in microglia after I/R, and that RSG delays neuronal damage by interfering with glial activations and increases anti-inflammatory cytokines in response to ischemic damage. (c) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available